AAPL293.17-1.13 (-0.38%) ▼|ABBV234.96+0.20 (+0.09%) ▲|ABT90.51-0.02 (-0.02%) ▼|ACN129.18+2.17 (+1.71%) ▲|ADBE196.55-0.88 (-0.45%) ▼|AMAT588.97+3.09 (+0.53%) ▲|AMD519.06-0.80 (-0.15%) ▼|AMGN351.40+4.39 (+1.26%) ▲|AMT174.46-4.92 (-2.74%) ▼|AMZN234.37+0.26 (+0.11%) ▲|AVGO382.08+1.93 (+0.51%) ▲|AXP342.62+4.84 (+1.43%) ▲|BA220.24+3.53 (+1.63%) ▲|BAC57.75-0.17 (-0.28%) ▼|BKNG181.28+12.34 (+7.30%) ▲|BLK982.14-33.19 (-3.27%) ▼|BMY55.01-0.53 (-0.95%) ▼|BNY143.56-3.73 (-2.53%) ▼|BRK-B494.90+2.09 (+0.42%) ▲|C143.77-1.21 (-0.83%) ▼|CAT994.57+10.33 (+1.05%) ▲|CL91.89+0.46 (+0.50%) ▲|CMCSA22.64-0.16 (-0.70%) ▼|COF200.51+2.70 (+1.36%) ▲|COP106.95-3.02 (-2.75%) ▼|COST960.97+3.29 (+0.34%) ▲|CRM152.80-0.62 (-0.40%) ▼|CSCO119.74-1.41 (-1.16%) ▼|CVS101.98+0.41 (+0.40%) ▲|CVX171.57-4.42 (-2.51%) ▼|DE601.64+9.70 (+1.64%) ▲|DHR188.89+9.92 (+5.54%) ▲|DIS101.18-2.36 (-2.27%) ▼|DUK126.50+1.45 (+1.16%) ▲|EMR141.53-1.61 (-1.12%) ▼|FDX317.23-0.01 (0.00%) ▼|GD344.53-5.81 (-1.66%) ▼|GE365.71+9.24 (+2.59%) ▲|GEV1,057.48+22.50 (+2.17%) ▲|GILD125.15+0.10 (+0.08%) ▲|GM78.98+0.03 (+0.03%) ▲|GOOG345.03-1.06 (-0.30%) ▼|GOOGL345.28-0.81 (-0.23%) ▼|GS1,076.55-17.89 (-1.63%) ▼|HD342.79+18.34 (+5.65%) ▲|HON227.42+5.05 (+2.27%) ▲|IBM262.94-2.00 (-0.75%) ▼|INTC131.91-0.37 (-0.28%) ▼|INTU262.33+4.28 (+1.66%) ▲|ISRG401.89-1.29 (-0.32%) ▼|JNJ241.02+1.94 (+0.81%) ▲|JPM333.49-0.66 (-0.20%) ▼|KO80.63+0.32 (+0.39%) ▲|LIN515.73+3.47 (+0.68%) ▲|LLY1,117.73+10.65 (+0.96%) ▲|LMT491.56-12.11 (-2.40%) ▼|LOW221.41+7.87 (+3.69%) ▲|LRCX374.82+3.49 (+0.94%) ▲|MA494.69+6.62 (+1.36%) ▲|MCD273.95+2.29 (+0.84%) ▲|MDLZ61.74+0.68 (+1.11%) ▲|MDT80.14-0.49 (-0.61%) ▼|META557.80-4.40 (-0.78%) ▼|MMM165.89+4.05 (+2.50%) ▲|MO72.06+0.45 (+0.63%) ▲|MRK120.65+1.05 (+0.88%) ▲|MS220.11-5.92 (-2.62%) ▼|MSFT365.45-8.50 (-2.27%) ▼|MU1,047.92-3.85 (-0.37%) ▼|NEE87.61+1.18 (+1.37%) ▲|NFLX71.85-0.98 (-1.34%) ▼|NKE41.89-0.50 (-1.17%) ▼|NOW93.83-2.12 (-2.20%) ▼|NVDA198.91-1.09 (-0.55%) ▼|ORCL157.64-7.52 (-4.55%) ▼|PEP142.27+0.22 (+0.15%) ▲|PFE24.05-0.67 (-2.71%) ▼|PG152.08+1.22 (+0.81%) ▲|PLTR113.51-3.19 (-2.73%) ▼|PM178.74+0.05 (+0.03%) ▲|QCOM197.33-6.81 (-3.33%) ▼|RTX185.03-1.36 (-0.73%) ▼|SBUX103.52+2.47 (+2.44%) ▲|SCHW91.40-1.77 (-1.90%) ▼|SO95.77+0.84 (+0.88%) ▲|SPG221.96+5.22 (+2.41%) ▲|T22.38-0.43 (-1.89%) ▼|TMO492.05+22.70 (+4.84%) ▲|TMUS180.79-3.78 (-2.05%) ▼|TSLA375.47-6.15 (-1.61%) ▼|TXN303.11-1.25 (-0.41%) ▼|UBER73.85+4.18 (+6.00%) ▲|UNH405.81-3.44 (-0.84%) ▼|UNP259.95+1.34 (+0.52%) ▲|UPS106.11+0.28 (+0.26%) ▲|USB60.11+0.06 (+0.10%) ▲|V332.37+3.89 (+1.18%) ▲|VZ45.73-1.00 (-2.14%) ▼|WFC84.31+0.18 (+0.21%) ▲|WMT119.01-0.41 (-0.34%) ▼|XOM136.92-2.81 (-2.01%) ▼|AAPL293.17-1.13 (-0.38%) ▼|ABBV234.96+0.20 (+0.09%) ▲|ABT90.51-0.02 (-0.02%) ▼|ACN129.18+2.17 (+1.71%) ▲|ADBE196.55-0.88 (-0.45%) ▼|AMAT588.97+3.09 (+0.53%) ▲|AMD519.06-0.80 (-0.15%) ▼|AMGN351.40+4.39 (+1.26%) ▲|AMT174.46-4.92 (-2.74%) ▼|AMZN234.37+0.26 (+0.11%) ▲|AVGO382.08+1.93 (+0.51%) ▲|AXP342.62+4.84 (+1.43%) ▲|BA220.24+3.53 (+1.63%) ▲|BAC57.75-0.17 (-0.28%) ▼|BKNG181.28+12.34 (+7.30%) ▲|BLK982.14-33.19 (-3.27%) ▼|BMY55.01-0.53 (-0.95%) ▼|BNY143.56-3.73 (-2.53%) ▼|BRK-B494.90+2.09 (+0.42%) ▲|C143.77-1.21 (-0.83%) ▼|CAT994.57+10.33 (+1.05%) ▲|CL91.89+0.46 (+0.50%) ▲|CMCSA22.64-0.16 (-0.70%) ▼|COF200.51+2.70 (+1.36%) ▲|COP106.95-3.02 (-2.75%) ▼|COST960.97+3.29 (+0.34%) ▲|CRM152.80-0.62 (-0.40%) ▼|CSCO119.74-1.41 (-1.16%) ▼|CVS101.98+0.41 (+0.40%) ▲|CVX171.57-4.42 (-2.51%) ▼|DE601.64+9.70 (+1.64%) ▲|DHR188.89+9.92 (+5.54%) ▲|DIS101.18-2.36 (-2.27%) ▼|DUK126.50+1.45 (+1.16%) ▲|EMR141.53-1.61 (-1.12%) ▼|FDX317.23-0.01 (0.00%) ▼|GD344.53-5.81 (-1.66%) ▼|GE365.71+9.24 (+2.59%) ▲|GEV1,057.48+22.50 (+2.17%) ▲|GILD125.15+0.10 (+0.08%) ▲|GM78.98+0.03 (+0.03%) ▲|GOOG345.03-1.06 (-0.30%) ▼|GOOGL345.28-0.81 (-0.23%) ▼|GS1,076.55-17.89 (-1.63%) ▼|HD342.79+18.34 (+5.65%) ▲|HON227.42+5.05 (+2.27%) ▲|IBM262.94-2.00 (-0.75%) ▼|INTC131.91-0.37 (-0.28%) ▼|INTU262.33+4.28 (+1.66%) ▲|ISRG401.89-1.29 (-0.32%) ▼|JNJ241.02+1.94 (+0.81%) ▲|JPM333.49-0.66 (-0.20%) ▼|KO80.63+0.32 (+0.39%) ▲|LIN515.73+3.47 (+0.68%) ▲|LLY1,117.73+10.65 (+0.96%) ▲|LMT491.56-12.11 (-2.40%) ▼|LOW221.41+7.87 (+3.69%) ▲|LRCX374.82+3.49 (+0.94%) ▲|MA494.69+6.62 (+1.36%) ▲|MCD273.95+2.29 (+0.84%) ▲|MDLZ61.74+0.68 (+1.11%) ▲|MDT80.14-0.49 (-0.61%) ▼|META557.80-4.40 (-0.78%) ▼|MMM165.89+4.05 (+2.50%) ▲|MO72.06+0.45 (+0.63%) ▲|MRK120.65+1.05 (+0.88%) ▲|MS220.11-5.92 (-2.62%) ▼|MSFT365.45-8.50 (-2.27%) ▼|MU1,047.92-3.85 (-0.37%) ▼|NEE87.61+1.18 (+1.37%) ▲|NFLX71.85-0.98 (-1.34%) ▼|NKE41.89-0.50 (-1.17%) ▼|NOW93.83-2.12 (-2.20%) ▼|NVDA198.91-1.09 (-0.55%) ▼|ORCL157.64-7.52 (-4.55%) ▼|PEP142.27+0.22 (+0.15%) ▲|PFE24.05-0.67 (-2.71%) ▼|PG152.08+1.22 (+0.81%) ▲|PLTR113.51-3.19 (-2.73%) ▼|PM178.74+0.05 (+0.03%) ▲|QCOM197.33-6.81 (-3.33%) ▼|RTX185.03-1.36 (-0.73%) ▼|SBUX103.52+2.47 (+2.44%) ▲|SCHW91.40-1.77 (-1.90%) ▼|SO95.77+0.84 (+0.88%) ▲|SPG221.96+5.22 (+2.41%) ▲|T22.38-0.43 (-1.89%) ▼|TMO492.05+22.70 (+4.84%) ▲|TMUS180.79-3.78 (-2.05%) ▼|TSLA375.47-6.15 (-1.61%) ▼|TXN303.11-1.25 (-0.41%) ▼|UBER73.85+4.18 (+6.00%) ▲|UNH405.81-3.44 (-0.84%) ▼|UNP259.95+1.34 (+0.52%) ▲|UPS106.11+0.28 (+0.26%) ▲|USB60.11+0.06 (+0.10%) ▲|V332.37+3.89 (+1.18%) ▲|VZ45.73-1.00 (-2.14%) ▼|WFC84.31+0.18 (+0.21%) ▲|WMT119.01-0.41 (-0.34%) ▼|XOM136.92-2.81 (-2.01%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: study

newssourceFORcompanyinformationcontent1marketreleases

CHAMPION IRON ENTERS INTO A DEFINITIVE AGREEMENT WITH NIPPON STEEL AND SOJITZ TO FORM A PARTNERSHIP FOR THE KAMI PROJECT

MONTRÉAL, July 21, 2025 /CNW/ - SYDNEY, July 22, 2025 - Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") announces...

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

UPDATE – Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference – The Sildenafil Cream That Raises the Bar

A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra® for men - in a proprietary topical formulation demonstrated to work where women need it most

Herzing University Launches Online Bachelor of Social Work Program

New BSW program aims to help students build foundational skills toward a life-changing career MILWAUKEE, July 21, 2025 /PRNewswire/ -- Herzing University an accredited, private nonprofit...

[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Laboratories, Artivion Inc., Athersys Inc., Baxter International Inc., Cellular Logistics Inc., Elutia Inc., Heartseed Inc., Medtronic Plc, Merck kGaA, Mesoblast Ltd., Neoolife Inc., Tejiin Limited, Terumo Corporation, and W.L. Gore & Associates, Inc and others. 
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Laboratories, Artivion Inc., Athersys Inc., Baxter International Inc., Cellular Logistics Inc., Elutia Inc., Heartseed Inc., Medtronic Plc, Merck kGaA, Mesoblast Ltd., Neoolife Inc., Tejiin Limited, Terumo Corporation, and W.L. Gore & Associates, Inc and others.

Natural Appetite Suppressant: Why More Are Choosing PhenQ Over Weight Loss Injections for Safer Weight Management Results in 2025

New York City, NY, July 21, 2025 (GLOBE NEWSWIRE) -- PhenQ is leading the 2025 weight loss revolution with a science-backed natural appetite suppressant—no needles, no harsh side effects, just sustainable, healthy weight control

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses...

ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to adequately disclose that Rocket Pharmaceuticals knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk.

Electric Vehicle Tires Market to Surge from USD 26.81 Billion in 2025 to USD 59.59 Billion by 2034

According to Towards Automotive consultants, the global electric vehicle tires market is projected to reach approximately USD 59.59 billion by 2034, increasing from USD 24.53 billion in 2024, at a CAGR of 9.45% during the forecast period 2025 to 2034. 
According to Towards Automotive consultants, the global electric vehicle tires market is projected to reach approximately USD 59.59 billion by 2034, increasing from USD 24.53 billion in 2024, at a CAGR of 9.45% during the forecast period 2025 to 2034.

CLL Society Awards Research Projects Advancing CLL/SLL Care

2025 Research Program supports innovative studies aimed at improving outcomes and quality of life for CLL and SLL patients SAN DIEGO, July 21, 2025 /PRNewswire/...

CENTURY LITHIUM REPORTS BATTERY-GRADE LITHIUM METAL ANODES PRODUCED FROM ANGEL ISLAND LITHIUM CARBONATE

VANCOUVER, BC, July 21, 2025 /CNW/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company") is pleased to report progress by Alpha-En...

CENTURY LITHIUM REPORTS BATTERY-GRADE LITHIUM METAL ANODES PRODUCED FROM ANGEL ISLAND LITHIUM CARBONATE

VANCOUVER, BC, July 21, 2025 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company") is pleased to report progress by Alpha-En...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStudy

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers